Results of Copeland Shoulder Resurfacing Arthroplasty in Sickle Cell Patients with Humeral Head Avascular Necrosis
Journal of Orthopedic Research and Therapy · 2022
DOI: 10.29011/2575-8241.001254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Orthopedic Research and Therapy, 2022.
Abstract (Originalsprache)
Introduction
Avascular Necrosis (AVN) of the humeral head is a debilitating complication of Sickle Cell Disease (SCD) estimated to occur in about 5% of patients for which the optimal therapy is not well defined.Although Copeland is often used for AVN in other settings, little information is available about the outcome of Copeland resurfacing in this population.The aim of this study was to evaluate the results of Copeland Shoulder Resurfacing Arthroplasty (CSRA) in sickle cell patients with humeral avascular necrosis.
Methods
Eleven CSRA were performed in eight patients with sickle cell disease from 2010 to 2014 in Sultan Qaboos University Hospital, Oman.Medical recorded, radiograph, operative note, clinical outcome, and complications were reviewed retrospectively with a mean follow-up of 4 years.
Results
Seven CSRA (63.6%) have improved in their pain and range of movement post-operatively.One patient developed stiffness that required arthroscopic capsular release.Three CSRA (27.3%) underwent revision to a total anatomical shoulder arthroplasty due to aseptic loosening (one patient) and glenoid arthrosis (two patients).Patients with high-grade AVN (stage 4 and 5) showed inferior results and satisfaction following CSRA.
Conclusion
Treatment of humeral head AVN in SCD patients is challenging.Copeland shoulder resurfacing arthroplasty may improve pain and function in selected SCD patients with early stages of humeral head AVN.
Zitieren
APA
(2022). Results of Copeland Shoulder Resurfacing Arthroplasty in Sickle Cell Patients with Humeral Head Avascular Necrosis. Journal of Orthopedic Research and Therapy. https://doi.org/10.29011/2575-8241.001254
Vancouver
Results of Copeland Shoulder Resurfacing Arthroplasty in Sickle Cell Patients with Humeral Head Avascular Necrosis. Journal of Orthopedic Research and Therapy. 2022. doi:10.29011/2575-8241.001254
BibTeX
@article{euvimed2022,
title = {Results of Copeland Shoulder Resurfacing Arthroplasty in Sickle Cell Patients with Humeral Head Avascular Necrosis},
journal = {Journal of Orthopedic Research and Therapy},
year = {2022},
doi = {10.29011/2575-8241.001254}
}
EUVIMED